# Metropolitan Bank Holding Corp.: financial statements, quarterly

MCB · NYSE · CIK 1476034 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mcb.md) · [Financials](/companies/mcb/financials.md) · [Filings](/companies/mcb/filings.md) · [Insiders](/companies/mcb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mcb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [6.6](/filings/0001558370-24-015052.md) | [6.5 d](/filings/0001104659-26-018208.md) | [7.0](/filings/0001558370-25-006192.md) | [6.1](/filings/0001558370-25-009986.md) | [6.2](/filings/0001104659-25-108171.md) | [4.5 d](/filings/0001104659-26-018208.md) | [3.6](/filings/0001104659-26-057925.md) | [2.6](/filings/0001104659-26-089011.md) | [2.5](/filings/0001104659-25-108171.md) | [2.4 d](/filings/0001104659-26-018208.md) | [2.6](/filings/0001104659-26-057925.md) | [2.6](/filings/0001104659-26-089011.md) |
| Interest expense | $m | [44.3](/filings/0001558370-23-017511.md) | [48.3 d](/filings/0001558370-24-001997.md) | [52.6](/filings/0001558370-24-006655.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [6.3](/filings/0001558370-24-015052.md) | [5.3 d](/filings/0001104659-26-018208.md) | [8.1](/filings/0001558370-25-006192.md) | [7.1](/filings/0001558370-25-009986.md) | [5.3](/filings/0001104659-25-108171.md) | [9.9 d](/filings/0001104659-26-018208.md) | [7.0](/filings/0001104659-26-057925.md) | [8.0](/filings/0001104659-26-089011.md) | [3.1](/filings/0001104659-25-108171.md) | [12.3 d](/filings/0001104659-26-018208.md) | [13.0](/filings/0001104659-26-057925.md) | [8.7](/filings/0001104659-26-089011.md) |
| Net income | $m | [22.1](/filings/0001558370-24-015052.md) | [14.6 d](/filings/0001104659-26-018208.md) | [16.2](/filings/0001558370-25-006192.md) | [16.8](/filings/0001558370-25-009986.md) | [12.3](/filings/0001104659-25-108171.md) | [21.4 d](/filings/0001104659-26-018208.md) | [16.4](/filings/0001104659-26-057925.md) | [18.8](/filings/0001104659-26-089011.md) | [7.1](/filings/0001104659-25-108171.md) | [28.9 d](/filings/0001104659-26-018208.md) | [31.4](/filings/0001104659-26-057925.md) | [19.2](/filings/0001104659-26-089011.md) |
| Diluted EPS | $ per share | [1.97](/filings/0001558370-24-015052.md) | not reported | [1.46](/filings/0001558370-25-006192.md) | [1.50](/filings/0001558370-25-009986.md) | [1.08](/filings/0001104659-25-108171.md) | not reported | [1.45](/filings/0001104659-26-057925.md) | [1.76](/filings/0001104659-26-089011.md) | [0.67](/filings/0001104659-25-108171.md) | not reported | [2.92](/filings/0001104659-26-057925.md) | [1.54](/filings/0001104659-26-089011.md) |
| Basic EPS | $ per share | [1.99](/filings/0001558370-24-015052.md) | not reported | [1.46](/filings/0001558370-25-006192.md) | [1.50](/filings/0001558370-25-009986.md) | [1.10](/filings/0001104659-25-108171.md) | not reported | [1.46](/filings/0001104659-26-057925.md) | [1.78](/filings/0001104659-26-089011.md) | [0.68](/filings/0001104659-25-108171.md) | not reported | [2.94](/filings/0001104659-26-057925.md) | [1.55](/filings/0001104659-26-089011.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [177](/filings/0001558370-23-017511.md) | [269](/filings/0001558370-25-001884.md) | [534](/filings/0001558370-24-006655.md) | [245](/filings/0001558370-24-010721.md) | [318](/filings/0001558370-24-015052.md) | [200](/filings/0001104659-26-018208.md) | [196](/filings/0001558370-25-006192.md) | [152](/filings/0001558370-25-009986.md) | [386](/filings/0001104659-25-108171.md) | [394](/filings/0001104659-26-089011.md) | [672](/filings/0001104659-26-057925.md) | [239](/filings/0001104659-26-089011.md) |
| Total assets | $m | [6,683](/filings/0001558370-23-017511.md) | [7,068](/filings/0001558370-25-001884.md) | [7,453](/filings/0001558370-24-006655.md) | [7,266](/filings/0001558370-24-010721.md) | [7,403](/filings/0001558370-24-015052.md) | [7,301](/filings/0001104659-26-018208.md) | [7,616](/filings/0001558370-25-006192.md) | [7,854](/filings/0001558370-25-009986.md) | [8,234](/filings/0001104659-25-108171.md) | [8,256](/filings/0001104659-26-089011.md) | [8,844](/filings/0001104659-26-057925.md) | [8,859](/filings/0001104659-26-089011.md) |
| Total liabilities | $m | [6,048](/filings/0001558370-23-017511.md) | [6,409](/filings/0001558370-25-001884.md) | [6,780](/filings/0001558370-24-006655.md) | [6,573](/filings/0001558370-24-010721.md) | [6,688](/filings/0001558370-24-015052.md) | [6,571](/filings/0001104659-26-018208.md) | [6,878](/filings/0001558370-25-006192.md) | [7,131](/filings/0001558370-25-009986.md) | [7,502](/filings/0001104659-25-108171.md) | [7,513](/filings/0001104659-26-089011.md) | [7,896](/filings/0001104659-26-057925.md) | [7,891](/filings/0001104659-26-089011.md) |
| Shareholders' equity | $m | [635](/filings/0001558370-24-015052.md) | [659](/filings/0001104659-26-018208.md) | [674](/filings/0001558370-25-009986.md) | [692](/filings/0001104659-25-108171.md) | [715](/filings/0001104659-25-108171.md) | [730](/filings/0001104659-26-089011.md) | [738](/filings/0001104659-26-089011.md) | [723](/filings/0001104659-26-089011.md) | [732](/filings/0001104659-25-108171.md) | [743](/filings/0001104659-26-089011.md) | [948](/filings/0001104659-26-089011.md) | [968](/filings/0001104659-26-089011.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [27.5 d](/filings/0001558370-24-015052.md) | [(30.7) d](/filings/0001104659-26-018208.md) | [25.0](/filings/0001558370-25-006192.md) | [35.3 d](/filings/0001558370-25-009986.md) | [4.8 d](/filings/0001104659-25-108171.md) | [83.4 d](/filings/0001104659-26-018208.md) | [7.8](/filings/0001104659-26-057925.md) | [18.4 d](/filings/0001104659-26-089011.md) | [31.8 d](/filings/0001104659-25-108171.md) | [30.7 d](/filings/0001104659-26-018208.md) | [55.0](/filings/0001104659-26-057925.md) | [(10.8) d](/filings/0001104659-26-089011.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [1.6 d](/filings/0001104659-26-018208.md) | [2.0](/filings/0001104659-26-057925.md) | [3.4 d](/filings/0001104659-26-089011.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | [12.9](/filings/0001104659-26-057925.md) | [37.6 d](/filings/0001104659-26-089011.md) | [2.7 d](/filings/0001104659-25-108171.md) | [20.2 d](/filings/0001104659-26-018208.md) | [9.9](/filings/0001104659-26-057925.md) | [0.0 d](/filings/0001104659-26-089011.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [11.2](/filings/0001558370-23-017511.md) | [11.1](/filings/0001558370-24-006655.md) | [11.3](/filings/0001558370-24-010721.md) | [11.1](/filings/0001558370-24-015052.md) | [11.1](/filings/0001558370-25-006192.md) | [11.2](/filings/0001558370-25-009986.md) | [11.3](/filings/0001104659-25-108171.md) | [11.3](/filings/0001104659-26-057925.md) | [10.7](/filings/0001104659-26-089011.md) | [10.6](/filings/0001104659-25-108171.md) | [10.8](/filings/0001104659-26-057925.md) | [12.5](/filings/0001104659-26-089011.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 12,397,778 at 2026-07-27, from the cover of the [10-Q filed 2026-07-31](/filings/0001104659-26-089011.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.